Want to see LUCY full AI Analyst Report?
Top Page
Innovative Eyewear, Inc.
(NASDAQ:LUCY)
Select Model
Select Model
Rating:50Neutral
Price Target:
$1.00
▼(-6.54% Downside)
Action:Reiterated
Date:08/25/26
The score is held down mainly by weak financial performance—large operating losses and significant cash burn—despite improving revenue and gross margin. Technicals are supportive with the stock trading above key moving averages, but overbought RSI limits upside confidence. Liquidity improved from the financing event, though potential dilution and a loss-making profile keep valuation and risk considerations moderate.
Positive Factors
Strong Revenue Growth
Rapid revenue growth indicates increasing demand for the company’s smart eyewear and improving commercial traction. Sustaining this expansion could help spread fixed costs across a larger sales base and support eventual operating leverage.
Negative Factors
Severe Operating Losses
The cost structure remains far too large for the current revenue base, despite positive gross margin. Persistent operating and net losses indicate that substantial scaling or significant cost reductions are required before the business can approach sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Rapid revenue growth indicates increasing demand for the company’s smart eyewear and improving commercial traction. Sustaining this expansion could help spread fixed costs across a larger sales base and support eventual operating leverage.
Read all positive factors
Innovative Eyewear, Inc. (LUCY) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$9.21M
Dividend YieldN/A
Average Volume (3M)543.31K
Price to Earnings (P/E)―
Beta (1Y)2.54
Revenue Growth72.50%
EPS Growth58.34%
CountryUS
Employees13
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-1.35
Shares Outstanding8,609,196
10 Day Avg. Volume196,778
30 Day Avg. Volume543,314
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.44
Price to Sales (P/S)1.49
P/FCF Ratio-0.53
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-1.23
Revenue Forecast (FY)$7.20M
Innovative Eyewear, Inc. Business Overview & Revenue Model
Company Description
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescr...
How the Company Makes Money
Innovative Eyewear primarily makes money by selling smart eyewear products (i.e., connected/smart glasses) through wholesale and direct-to-consumer channels. Key revenue streams include: (1) product sales of smart glasses and related eyewear units...
Innovative Eyewear, Inc. Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
58
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.41M | 2.66M | 1.64M | 1.15M | 659.79K | 690.67K |
| Gross Profit | 777.54K | 567.45K | 215.19K | -119.33K | -56.29K | 148.25K |
| EBITDA | -7.60M | -7.46M | -7.62M | -6.58M | -5.54M | -3.20M |
| Net Income | -7.69M | -7.59M | -7.77M | -6.66M | -5.68M | -3.24M |
Balance Sheet | ||||||
| Total Assets | 7.47M | 10.14M | 9.84M | 6.22M | 4.69M | 824.32K |
| Cash, Cash Equivalents and Short-Term Investments | 3.74M | 6.51M | 7.52M | 4.29M | 3.59M | 79.73K |
| Total Debt | 49.40K | 0.00 | 0.00 | 0.00 | 61.36K | 289.03K |
| Total Liabilities | 574.38K | 1.07M | 743.17K | 659.94K | 665.46K | 616.80K |
| Stockholders Equity | 6.90M | 9.07M | 9.10M | 5.56M | 4.02M | 207.52K |
Cash Flow | ||||||
| Free Cash Flow | -7.39M | -7.53M | -7.01M | -6.02M | -3.44M | -1.33M |
| Operating Cash Flow | -7.20M | -7.28M | -6.74M | -5.77M | -3.22M | -1.21M |
| Investing Cash Flow | -262.15K | 4.48M | -5.16M | -198.75K | -219.95K | -118.45K |
| Financing Cash Flow | 2.29M | 6.68M | 10.24M | 6.66M | 6.96M | 1.39M |
Innovative Eyewear, Inc. Technical Analysis
Positive
1.07
Price Trends
0.82
Positive
0.91
Positive
1.10
Positive
Market Momentum
0.05
Negative
70.96
Negative
69.55
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LUCY, the sentiment is Positive. The current price of 1.07 is above the 20-day moving average (MA) of 0.77, above the 50-day MA of 0.82, and below the 200-day MA of 1.10, indicating a bullish trend. The MACD of 0.05 indicates Negative momentum. The RSI at 70.96 is Negative, neither overbought nor oversold. The STOCH value of 69.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for LUCY.
Innovative Eyewear, Inc. Risk Analysis
Innovative Eyewear, Inc. disclosed 40 risk factors in its most recent earnings report. Innovative Eyewear, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Innovative Eyewear, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $6.16B | -36.07 | -2.67% | ― | 8.85% | 37.70% | |
60 Neutral | $48.27M | -6.55 | -37.47% | ― | 64.18% | 28.90% | |
57 Neutral | $14.25B | 61.59 | 2.84% | ― | 6.09% | -42.65% | |
55 Neutral | $1.16B | 285.75 | 1.08% | ― | 51.30% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $9.21M | -0.84 | -83.38% | ― | 72.50% | 58.34% |
* Healthcare Sector Average
LUCY
Innovative Eyewear, Inc.
1.13
-0.82
-42.05%
COO
Cooper Co
72.68
-1.42
-1.92%
STAA
Staar Surgical
22.86
-4.65
-16.90%
POCI
Precision Optics Corporation
4.35
-0.47
-9.75%
BLCO
Bausch + Lomb Corporation
17.25
2.70
18.56%
Innovative Eyewear, Inc. Corporate Events
Private Placements and Financing
Innovative Eyewear Raises $3 Million via Warrant Inducement
Positive
Jul 9, 2026
On July 8, 2026, Innovative Eyewear entered into an inducement agreement with a warrant holder to spur the cash exercise of 2,200,544 existing warrants at a reduced price of $1.35 per share, compared with the original $2.60 exercise price. In retu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.